AnaptysBio Depreciation And Amortization from 2010 to 2024

ANAB Stock  USD 21.00  2.13  11.29%   
AnaptysBio's Depreciation And Amortization is increasing over the years with slightly volatile fluctuation. Overall, Depreciation And Amortization is expected to go to about 2.8 M this year. Depreciation And Amortization is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. View All Fundamentals
 
Depreciation And Amortization  
First Reported
2014-09-30
Previous Quarter
592 K
Current Value
604 K
Quarterly Volatility
M
 
Yuan Drop
 
Covid
Check AnaptysBio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AnaptysBio main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.8 M, Interest Expense of 19 M or Selling General Administrative of 44 M, as well as many exotic indicators such as Price To Sales Ratio of 31.93, Dividend Yield of 0.0 or PTB Ratio of 6.22. AnaptysBio financial statements analysis is a perfect complement when working with AnaptysBio Valuation or Volatility modules.
  
This module can also supplement AnaptysBio's financial leverage analysis and stock options assessment as well as various AnaptysBio Technical models . Check out the analysis of AnaptysBio Correlation against competitors.
For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.

Latest AnaptysBio's Depreciation And Amortization Growth Pattern

Below is the plot of the Depreciation And Amortization of AnaptysBio over the last few years. It is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. AnaptysBio's Depreciation And Amortization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AnaptysBio's overall financial position and show how it may be relating to other accounts over time.
Depreciation And Amortization10 Years Trend
Slightly volatile
   Depreciation And Amortization   
       Timeline  

AnaptysBio Depreciation And Amortization Regression Statistics

Arithmetic Mean2,154,007
Geometric Mean880,569
Coefficient Of Variation148.82
Mean Deviation2,325,209
Median580,000
Standard Deviation3,205,590
Sample Variance10.3T
Range10.8M
R-Value0.47
Mean Square Error8.6T
R-Squared0.22
Significance0.08
Slope338,331
Total Sum of Squares143.9T

AnaptysBio Depreciation And Amortization History

20242.8 M
20232.4 M
20227.6 M
2021468 K
20204.5 M
201911 M
2018315 K

About AnaptysBio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include AnaptysBio income statement, its balance sheet, and the statement of cash flows. AnaptysBio investors use historical funamental indicators, such as AnaptysBio's Depreciation And Amortization, to determine how well the company is positioned to perform in the future. Although AnaptysBio investors may use each financial statement separately, they are all related. The changes in AnaptysBio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AnaptysBio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AnaptysBio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AnaptysBio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Depreciation And Amortization2.4 M2.8 M

Pair Trading with AnaptysBio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AnaptysBio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will appreciate offsetting losses from the drop in the long position's value.

Moving together with AnaptysBio Stock

  0.63DVAX Dynavax Technologies Financial Report 7th of May 2024 PairCorr
  0.64VTRS Viatris Earnings Call This WeekPairCorr
  0.84EGRX Eagle PharmaceuticalsPairCorr
  0.65ELAN Elanco Animal Health Financial Report 14th of May 2024 PairCorr

Moving against AnaptysBio Stock

  0.8ACB Aurora Cannabis Sell-off TrendPairCorr
  0.79CGC Canopy Growth Corp Financial Report 27th of June 2024 PairCorr
  0.6FLGC Flora Growth Corp Financial Report 20th of May 2024 PairCorr
  0.46HCM HUTCHMED DRCPairCorr
The ability to find closely correlated positions to AnaptysBio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AnaptysBio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AnaptysBio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AnaptysBio to buy it.
The correlation of AnaptysBio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AnaptysBio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AnaptysBio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AnaptysBio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AnaptysBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AnaptysBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anaptysbio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anaptysbio Stock:
Check out the analysis of AnaptysBio Correlation against competitors.
For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.
Note that the AnaptysBio information on this page should be used as a complementary analysis to other AnaptysBio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for AnaptysBio Stock analysis

When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is AnaptysBio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AnaptysBio. If investors know AnaptysBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AnaptysBio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.08)
Revenue Per Share
0.637
Quarterly Revenue Growth
0.323
Return On Assets
(0.18)
Return On Equity
(0.93)
The market value of AnaptysBio is measured differently than its book value, which is the value of AnaptysBio that is recorded on the company's balance sheet. Investors also form their own opinion of AnaptysBio's value that differs from its market value or its book value, called intrinsic value, which is AnaptysBio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AnaptysBio's market value can be influenced by many factors that don't directly affect AnaptysBio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AnaptysBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if AnaptysBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnaptysBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.